NDC 13913-012-01 - Cambia
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13913-012
- Requested NDC
- 13913-012-01
- Package NDCs from labels
- 13913-012-01, 13913-012-03, 13913-012-02
- Manufacturer
- Assertio Therapeutics, Inc.
- Effective date
- 2024-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cambia - Assertio Therapeutics, Inc. | Assertio Therapeutics, Inc. | 2024-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13913-012-01 | Cambia | 1 in 1 PACKET | POWDER, FOR SOLUTION | 1 | 9 | |
| 13913-012-02 | Cambia | 1 in 1 PACKET | POWDER, FOR SOLUTION | 1 | 9 | |
| 13913-012-02 | Cambia | 9 in 1 CARTON | POWDER, FOR SOLUTION | 9 | 9 | |
| 13913-012-03 | Cambia | 9 in 1 CARTON | POWDER, FOR SOLUTION | 9 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13913-012-01 | EA - Each | 13913-012 | a4afaf38-fa08-4e82-ae9a-1cfd685736fb | 1 | 2016-11-08 |
| 13913-012-03 | EA - Each | 13913-012 | c3596580-b003-4c2f-aa16-8cf4a3bbad33 | 1 | 2016-11-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Teva Pharmaceuticals USA, Inc. | 77b60a0c-e49a-4ad4-abb1-b662c24ab782 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Archis Pharma LLC | 0d83cab3-c698-4763-9e77-27d72ba94e30 | 2024-12-30 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Advanced Rx of Tennessee, LLC | 295d167c-eb56-8e14-e063-6394a90ad325 | 2024-12-16 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Advanced Rx of Tennessee, LLC | 295d5dab-8890-d76e-e063-6394a90ad402 | 2024-12-16 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM, FILM COATED | Cintex Services, LLC | 0cdea9d3-fada-b00e-e063-6394a90ad5d9 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Cambia | DICLOFENAC POTASSIUM | Assertio Therapeutics, Inc. | d249ced1-4ca0-4f57-adcb-23440f58f659 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | NDA022165 13913-012-03 13913-012-01 13913-012-02 13913-012 13913001201 859066 859063 b9a3d927-3dc3-4860-ac3b-3dd20df47dd6 d249ced1-4ca0-4f57-adcb-23440f58f659 L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Aurobindo Pharma Limited | 7efdbe23-503a-4f38-a0b6-c003033f0de7 | 2024-12-07 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | NuCare Pharmaceuticals, Inc. | 26a8f723-2a8e-8a5a-e063-6394a90a7bae | 2024-11-11 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | NuCare Pharmaceuticals, Inc. | 3da9e463-1b2f-54c0-e054-00144ff88e88 | 2024-08-13 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | 3OWL53L36A |
| LOFENA | DICLOFENAC POTASSIUM | Carwin Pharmaceutical Associates, LLC | 49bd64cc-5edb-44f2-8e24-1249f6a76663 | 2024-01-08 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM | Leading Pharma, LLC | 9dd418b2-4b0e-498c-b453-f580c69ddc6d | 2024-01-04 | Boxed warning, Warnings, Adverse reactions | NDA022165 859063 L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | A-S Medication Solutions | 112e7c94-23c8-451e-ae71-eb89a6eb2cb2 | 2023-11-24 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Carwin Pharmaceutical Associates, LLC | bce95bb3-3097-4e7d-8d29-0870bb729212 | 2023-11-08 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM TABLETS | A-S Medication Solutions | 5d37fc5a-7a2f-432e-b4e9-e00c246ce33c | 2023-10-26 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Bryant Ranch Prepack | 717341fc-e067-0005-215c-053f6d12e0d1 | 2023-10-03 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Proficient Rx LP | 94586867-c75b-4d60-be1d-03a9e4b7cd10 | 2023-09-01 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM, FILM COATED | Havix Group Inc d-b-a Aavis Pharmaceuticals | 30ab7b30-cc90-4b84-8caf-21058f1d37fa | 2023-06-27 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.